Related Experiment Video
Updated: Jun 7, 2025

In Utero Intra-cardiac Tomato-lectin Injections on Mouse Embryos to Gauge Renal Blood Flow
Published on: February 4, 2015
Gitelman syndrome patient managed with amiloride during pregnancy and lactation
Abdelrahman Ibrahim1, Aylin R Rodan1, Christof Westenfelder1
1Nephrology Division, Department of Internal Medicine, University of Utah Health, Salt Lake City, USA.
None:
Gitelman Syndrome (GS) is a rare autosomal-recessive tubular disorder characterized by hypokalemia, hypomagnesemia, metabolic alkalosis, hyperreninemic hyperaldosteronism, and normotension. Management of GS during pregnancy is particularly challenging due to pregnancy-associated renal physiological changes and due to controversial safety profiles regarding teratogenicity of medications commonly used for GS management in non-pregnant patients. We report a case of a 20-year-old female patient diagnosed of GS who was treated with amiloride during pregnancy and lactation due to persistent hypokalemia resistant to oral supplementation therapy. Use of amiloride facilitated control of hypokalemia and hypomagnesemia in the mother without causing any noticeable side effects in the newborn.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Mitral Regurgitation IV: Nursing Management
Mitral Valve Prolapse III: Nursing Management
Mitral Regurgitation III: Medical Management
Hormonal Regulation
Mania and Antimanic Drugs: Overview

